Skip to content

Avanos Medical AVNS Payments for Legal Settlements

Payments for Legal Settlements at other companies

Avanos Medical logo
Avanos MedicalAVNS
$0
Bausch Health Companies logo
Bausch Health CompaniesBHC
$161M+747%
Colgate-Palmolive logo
Colgate-PalmoliveCL
$0-100%
McKesson logo
McKessonMCK
-$15M0.0%
Aeva Technologies logo
Aeva TechnologiesAEVA
$0
T-Mobile US logo
T-Mobile USTMUS
$350M0.0%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForLegalSettlements.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's payments for legal settlements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's payments for legal settlements?
Avanos Medical (AVNS) reported payments for legal settlements of $0 in Q1 2026.
What is the long-term trend for Avanos Medical's payments for legal settlements?
Over 4 years (2021 to 2025), Avanos Medical's payments for legal settlements has grown at a -100.0% compound annual growth rate (CAGR), from $15M to $0.
What does payments for legal settlements mean?
Cash outflows related to the resolution of legal disputes, lawsuits, or regulatory investigations. Monitoring these payments is essential for assessing potential litigation risks and the impact of non-recurring legal costs on operating cash flow.